Over 1.4 million Australians are living with Chronic Obstructive Pulmonary Disease, or COPD, with as many as one in 20 people over the age of 55 affected by the condition. Although understanding of COPD has improved significantly in recent years, we are constantly seeking new avenues to explore in our relentless pursuit for better breathing.

Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?

By the time the second hand on your wristwatch has circled its dial, a child in Africa will have died of malaria.

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries

Back to top